
Feb 5 (Reuters) - Pasithea Therapeutics Corp KTTA.O:
PASITHEA THERAPEUTICS ANNOUNCES POSITIVE SAFETY REVIEW COMMITTEE (SRC) RECOMMENDATION FROM ITS ONGOING PHASE 1 CLINICAL TRIAL OF PAS-004 IN ADVANCED CANCER
Source text: ID:nGNXf0tb0
Further company coverage: KTTA.O